The history of tumor virology

Cancer Research

Volumn 68, Issue 19, 2008, Pages 7693-7706

  Javier, Ronald T ^a   Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; PROTEIN P53;

DNA TUMOR VIRUS; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HISTORY OF MEDICINE; HUMAN; KAPOSI SARCOMA; LIVER CELL CARCINOMA; ONCOGENE; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; RNA TUMOR VIRUS; T CELL LEUKEMIA; TUMOR VIRUS; UTERINE CERVIX CANCER; VIROLOGY;

ANIMALS; BIRD DISEASES; BIRDS; GENES, TUMOR SUPPRESSOR; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENIC VIRUSES; VIROLOGY; VIRUS PHYSIOLOGICAL PHENOMENA;

EID: 54249127873     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3301     Document Type: Review

References (115)

1. Mackay J, Jemal A, Lee NC, Parkin DM. The history of cancer. The Cancer Atlas, 1st ed. American Cancer Society; 2006.
2. Diamandopoulos GT. Cancer: an historical perspective. Anticancer Res 1996;16:1595-602.
3. Gallucci BB. Selected concepts of cancer as a disease: from the Greeks to 1900. Oncol Nurs Forum 1985;12:67-71.
4. Kardinal CG, Yarbro JW. A conceptual history of cancer. Semin Oncol 1979;6:396-408.
5. Levine AJ. The Origins of Virology, In: Knipe DM, Howley PM, editors. Fields virology, 4th ed, vol. 1. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 3-18.
6. Ciuffo G. Innesto positivo con filtrato di verruca volgare. Giorn Ital Mal Venereol 1907;48:12-7.
7. Ellermann V, Bang O. Experimentelle leukamie bei huhnern. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 1908;46:595-7.
8. Epstein MA. Historical background. Philos Trans R Soc Lond B Biol Sci 2001;356:413-20.
9. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 1911;13:397-9.
10. Rous P. A transmissable avian neoplasm. J Exp Med 1910;12:696-705.
11. Vogt PK. Peyton Rous: homage and appraisal. FASEB J 1996;10:1559-62.
12. Shope RE, Hurst EW. Infectious papillomatosis of rabbits; with a note on the histopathology. J Exp Med 1933;58:607-24.
13. Rous P, Beard JW. The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med 1935;62:523-48.
14. Bittner JJ. Some possible effects of nursing on the mammary tumor incidence in mice. Science 1936;84:162-9.
15. Gross L. "Spontaneous" leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos. Proc Soc Exp Biol Med 1951;76:27-32.
16. Gross L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc Soc Exp Biol Med 1953;83:414-21.
17. Friend C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med 1957;105:307-18.
18. Graffi A. Chloroleukemia of mice. Ann N Y Acad Sci 1957;68:540-58.
19. Moloney JB. Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations. J Natl Cancer Inst 1960;24:933-51.
20. Hilleman MR, Werner JH. Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med 1954;85:183-8.
21. Rowe WP, Huebner RJ, Gilmore LK, Parrott RH, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1953;84:570-3.
22. Trentin JJ, Yabe Y, Taylor G. The quest for human cancer viruses. Science 1962;137:835-41.
23. Sweet BH, Hilleman MR. The vacuolating virus, SV40. Proc Soc Exp Biol Med 1960;105:420-7.
24. Eddy BE, Borman GS, Grubbs GE, Young RD. Identification of the oncogenic substance in rhesus monkey kidney cell culture as simian virus 40. Virology 1962;17:65-75.
25. Girardi AJ, Sweet BH, Slotnick VB, Hilleman MR. Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med 1962;109:649-60.
26. Burkitt D. A children's cancer dependent on climatic factors. Nature 1962;194:232-4.
27. Levine AJ. Viruses. New York: Scientific American Library; 1991.
28. Epstein MA, Henle G, Achong BG, Barr YM. Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J Exp Med 1965;121:761-70.
29. Henle G, Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol 1966;91:1248-56.
30. Liao JB. Viruses and human cancer. Yale J Biol Med 2006;79:115-22.
31. Pagano JS, Blaser M, Buendia MA, et al. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 2004;14:453-71.
32. Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM, Howley PM, editors. Fields virology, 4th ed, vol. 2. Philadelphia: Lipppincott Williams & Wilkins; 2001. p. 2971-3036.
33. Blumberg BS, Alter HJ, Visnich S. A "new" antigen in leukemia sera. JAMA 1965;191:541-6.
34. Blumberg BS, Gerstley BJ, Hungerford DA, London WT, Sutnick AI. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med 1967;66:924-31.
35. Okochi K, Murakami S. Observations on Australia antigen in Japanese. Vox Sang 1968;15:374-85.
36. Prince AM. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A 1968;60:814-21.
37. Ganem D, Schneider R. Hepadnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editor. Fields virology, 4th ed, vol. 2. Philadelphia: Lipppincott Williams & Wilkins; 2001. p. 2923-70.
38. Blumberg BS, Larouze B, London WT, et al. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 1975;81:669-82.
39. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981;2:1129-33.
40. Buynak EB, Roehm RR, Tytell AA, Bertland AU II, Lampson GP, Hilleman MR. Vaccine against human hepatitis B. JAMA 1976;235:2832-4.
41. Hilleman MR. Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 2003;21:4626-49.
42. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-9.
43. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
44. Olson C, Pamukcu AM, Brobst DF, Kowalczyk T, Satter EJ, Price JM. A urinary bladder tumor induced by a bovine cutaneous papilloma agent. Cancer Res 1959;19:779-82.
45. Jablonska S, Dabrowski J, Jakubowicz K. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 1972;32:583-9.
46. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976;36:794.
47. zur Hausen H, Meinhof W, Scheiber W, Bornkamm GW. Attempts to detect virus-specific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int J Cancer 1974;13:650-6.
48. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984;3:1151-7.
49. Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983;80:3812-5.
50. Frazer IH, Lowy DR, Schiller JT. Prevention of cancer through immunization: prospects and challenges for the 21st century. Eur J Immunol 2007;37 Suppl 1:S148-55.
51. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
52. Ghim SJ, Jenson AB, Schlegel R. HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology 1992;190:548-52.
53. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci U S A 1992;89:12180-4.
54. Rose RC, Bonnez W, Reichman RC, Garcea RL. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles. J Virol 1993;67:1936-44.
55. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991;185:251-7.
56. Schiller JT, Lowy DR. Prospects for cervical cancer prevention by human papillomavirus vaccination. Cancer Res 2006;66:10229-32.
57. Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000;21:405-26.
58. Keogh EV. Ectodermal lesions produced by the virus of Rous sarcoma. Br J Exp Path 1938;19:1-9.
59. Temin HM, Rubin H. Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 1958;6:669-88.
60. Martin GS. The road to Src. Oncogene 2004;23:7910-7.
61. Duesberg PH, Vogt PK. Differences between the ribonucleic acids of transforming and nontransforming avian tumor viruses. Proc Natl Acad Sci U S A 1970;67:1673-80.
62. Temin HM. The effects of actinomycin D on growth of rous sarcoma virus in vitro . Virology 1963;20:577-82.
63. Temin HM. The participation of DNA in Rous sarcoma virus production. Virology 1964;23:486-94.
64. Temin HM. Nature of the provirus of Rous sarcoma. Nat Cancer Inst Monograph 1964;17:557-70.
65. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970;226:1209-11.
66. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970;226:1211-3.
67. Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A 1969;64:1087-94.
68. Stehelin D, Varmus HE, Bishop JM, Vogt PK. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 1976;260:170-3.
69. Parada LF, Tabin CJ, Shih C, Weinberg RA. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 1982;297:474-8.
70. Der CJ, Krontiris TG, Cooper GM. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci U S A 1982;79:3637-40.
71. Sukumar S, Notario V, Martin-Zanca D, Barbacid M. Induction of mammary carcinomas in rats by nitrosomethylurea involves malignant activation of H-ras-1 locus by single point mutations. Nature 1983;306:658-61.
72. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278:261-3.
73. Linzer DI, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979;17:43-52.
74. Brugge JS, Butel JS. Role of simian virus 40 gene A function in maintenance of transformation. J Virol 1975;15:619-35.
75. Martin RG, Chou JY. Simian virus 40 functions required for the establishment and maintenance of malignant transformation. J Virol 1975;15:599-612.
76. Tegtmeyer P. Function of simian virus 40 gene A in transforming infection. J Virol 1975;15:613-8.
77. Braithwaite AW, Prives CL. p53: more research and more questions. Cell Death Differ 2006;13:877-80.
78. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science 1989;244:207-11.
79. Finlay CA, Hinds PW, Levine AJ. The p53 protooncogene can act as a suppressor of transformation. Cell 1989;57:1083-93.
80. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.
81. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
82. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:747-9.
83. Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-3.
84. Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643-6.
85. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987;235:1394-9.
86. DeCaprio JA, Ludlow JW, Figge J, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988;54:275-83.
87. Whyte P, Buchkovich KJ, Horowitz JM, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988;334:124-9.
88. Nevins J. Cell transformation by viruses, In: Knipe DM, Howley PM, editors. Fields virology, 4th ed, vol. 1. Philadelphia: Lipppincott Williams & Wilkins; 2001. p. 245-84.
89. Kovesdi I, Reichel R, Nevins JR. Identification of a cellular transcription factor involved in E1A transactivation. Cell 1986;45:219-28.
90. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
91. Hickman ES, Moroni MC, Helin K. The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 2002;12:60-6.
92. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
93. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-9.
94. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 1981;78:6476-80.
95. Matsuoka M, Jeang KT, Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007;7:270-80.
96. Major ME, Rehermann B, Feinstone SM, Hepatitis C viruses. In: Knipe DM, Howley PM, editors. Fields virology, vol. 1. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1127-62.
97. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-62.
98. Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989;321:1494-500.
99. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-364.
100. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-8.
101. Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ. Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008;28:175-88.
102. Ganem D. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 2006;1:273-96.
103. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-51.
104. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
105. McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta 2008;1782:127-50.
106. Bilder D. Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev 2004;18:1909-25.
107. Dow LE, Humbert PO. Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis. Int Rev Cytol 2007;262:253-302.
108. Butel JS. SV40, human infections, and cancer: emerging concepts and causality considerations. In: Khalili K, Jeang KT, editors. Viral oncology: basic to clinical perspectives. J Wiley. In press 2008.
109. White MK, Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 2004;324:1-16.
110. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-100.
111. Alemany R. Cancer selective adenoviruses. Mol Aspects Med 2007;28:42-58.
112. Cross D, Burmester JK. Gene therapy for cancer treatment: past, present and future. Clin Med Res 2006;4:218-27.
113. Weinberg RA. The biology of cancer. New York: Garland Science; 2007.
114. Khuri FR, Nemunaitis J, Ganly I, et al. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med 2000;6:879-85.
115. Lamont JP, Nemunaitis J, Kuhn JA, Landers SA, McCarty TM. A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the Baylor experience). Ann Surg Oncol 2000;7:588-92.